Casdin Capital, LLC

Holdings History for Neurogene Inc. - Common Stock, $0.000001 par value (NGNE)

Symbol: NGNE on Nasdaq
Investment type: Equity / Common Stock, $0.000001 par value
Latest Disclosed Shares Owned: 1,295,361 shares
Security Ownership %: 8.7%

Shares, Excluding Options vs Price

Value, Excluding Options

Casdin Capital, LLC ownership in Neurogene Inc. Common Stock, $0.000001 par value (NGNE)

14 Feb 2025 - Casdin Capital, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,295,361 shares of Neurogene Inc. Common Stock, $0.000001 par value (NGNE). This represents 8.7% ownership of the company. This is the first filing by Casdin Capital, LLC disclosing ownership of Neurogene Inc. Common Stock, $0.000001 par value (NGNE).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Casdin Capital, LLC	8.7%		$19,961,513	1,295,361			$15.41	13G/A	31 Dec 2024	14 Feb 2025, 16:00

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	1.7%	0%	$26,684,437	1,295,361	0		$20.60	Q4 2025
30 Sep 2025	1.9%	0%	$22,448,606	1,295,361	0		$17.33	Q3 2025
30 Jun 2025	1.8%	0%	$19,365,647	1,295,361	0		$14.95	Q2 2025
31 Mar 2025	1.2%	0%	$15,168,677	1,295,361	0		$11.71	Q1 2025
31 Dec 2024	2%	+1.2%	$29,611,952	1,295,361	+770,745	+147%	$22.86	Q4 2024
30 Sep 2024	1.5%	0%	$22,012,887	524,616	0		$41.96	Q3 2024
30 Jun 2024	1.5%	0%	$19,090,776	524,616	0		$36.39	Q2 2024
31 Mar 2024	2%	0%	$26,702,954	524,616	0		$50.90	Q1 2024
31 Dec 2023	1%	+1%	$10,167,058	524,616	+524,616	NEW	$19.38	Q4 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.